Zexi Hu

816 total citations
8 papers, 163 citations indexed

About

Zexi Hu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zexi Hu has authored 8 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zexi Hu's work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Zexi Hu is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Zexi Hu collaborates with scholars based in China, United States and Germany. Zexi Hu's co-authors include Yinghua Hu, Jiang Yayun, Jianzhong Xiao, Barbara V. Howard, Jinping Wang, Guangwei Li, Peter H. Bennett, Wenying Yang, Tao Sun and Xiang‐Dong Fu and has published in prestigious journals such as Gastroenterology, PLoS ONE and FEBS Letters.

In The Last Decade

Zexi Hu

8 papers receiving 159 citations

Peers

Zexi Hu

MB

EDM

PHYSI

ONCOL

PRM

Reza Sahebi Iran

Young-Soo Song South Korea

Guinevere A. Murphy United States

Paweł Kozieł Poland

Yoshinori Osaki Japan

Laurence McEvoy United Kingdom

Xunjun Xiao United States

Gillian C. Sibbring United Kingdom

Benjamin Bourgeois Austria

Diljit Kaur‐Knudsen Denmark

Reza Sahebi Iran

Zexi Hu

147 ×2.1

MB

24 ×0.4

EDM

46 ×1.8

PHYSI

33 ×1.4

ONCOL

16 ×1.0

PRM

Citations per year, relative to Zexi Hu Zexi Hu (= 1×) peers Reza Sahebi

Countries citing papers authored by Zexi Hu

Since Specialization

Citations

This map shows the geographic impact of Zexi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zexi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zexi Hu more than expected).

Fields of papers citing papers by Zexi Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zexi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zexi Hu. The network helps show where Zexi Hu may publish in the future.

Co-authorship network of co-authors of Zexi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zexi Hu. A scholar is included among the top collaborators of Zexi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zexi Hu. Zexi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Serafim, Ricardo A. M., André da Silva Santiago, Martin P. Schwalm, et al.. (2022). Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor. Journal of Medicinal Chemistry. 65(4). 3173–3192. 20 indexed citations

2.

Hu, Zexi, Thales Kronenberger, Jenni Küblbeck, et al.. (2022). Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 65(6). 4616–4632. 21 indexed citations

3.

Xing, Jun, Khắc Cường Bùi, Zexi Hu, et al.. (2020). Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition. Cancers. 12(3). 615–615. 13 indexed citations

4.

Armbruster, Nicole, Zexi Hu, Benjamin A. H. Jensen, et al.. (2018). 129 - Oral Delivery of Human Beta-Defensin 2 is Reversibly Increasing Microbiome Diversity and is Effective in the Treatment of Experimental Colitis. Gastroenterology. 154(6). S–34. 1 indexed citations

5.

Hu, Zexi, Yong Hu, Xicheng Liu, et al.. (2015). Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor. Oncotarget. 6(31). 31628–31639. 3 indexed citations

6.

Hu, Zexi, Xiaobo Wan, Rui Hao, et al.. (2015). Phosphorylation of Mutationally Introduced Tyrosine in the Activation Loop of HER2 Confers Gain-of-Function Activity. PLoS ONE. 10(4). e0123623–e0123623. 7 indexed citations

7.

Liu, Wei, Yu Zhou, Zexi Hu, et al.. (2010). Regulation of splicing enhancer activities by RNA secondary structures. FEBS Letters. 584(21). 4401–4407. 18 indexed citations

8.

Li, Guangwei, Yinghua Hu, Wenying Yang, et al.. (2002). Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study. Diabetes Research and Clinical Practice. 58(3). 193–200. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact